Global Tuberculosis Therapeutics Market: Overview
Mycobacterium tuberculosis is the bacteria that cause the chronic infectious disease tuberculosis. Pulmonary tuberculosis is the alternate name for tuberculosis. In this disease, the bacteria majorly infects any part of the body, mainly it is the lungs that are affected. When the infection is spread to the other parts of the body then extrapulmonary tuberculosis occurs. This bacterial infection spreads through the lymph nodes or by the bloodstream to any organ of the body. Tuberculosis is a contagious disease. It is transmitted from one person to another person by the microscopic droplets that are released into the air by the infected person. Tuberculosis mainly occurs in two types–active tuberculosis and latent tuberculosis.
Global Tuberculosis Therapeutics Market: Segmentation
The global tuberculosis therapeutics market is fragmented into end user and product. On the basis of the end user, the market is segmented into ambulatory surgical centers, hospital pharmacies, and individual pharmacies. Based on the product, the market is categorized into isoniazid, rifampin, pyrazinamide, hydrazine derivatives, miscellaneous anti-tubercular drugs, and ethambutol.
|Historic Years||2016 - 2020|
|Forecast Years||2021 - 2028|
|Segments Covered||By Product Type, By Application, and By End Use|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Quantitative Units||Revenue in USD million/billion and CAGR from 2021 to 2028|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World|
|Countries Covered||U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Number of Companies Covered||10 companies with scope for including additional 15 companies upon request|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.|
|Customization Scope||Avail customized purchase options to meet your exact research needs.|
Global Tuberculosis Therapeutics Market: Growth Factors
Increasing rate of occurrences of tuberculosis will provide lucrative opportunities for the global tuberculosis therapeutics market growth. According to the World Health Organization, approximately one-third of the total world’s population was diagnosed with latent tuberculosis. The regions that are more prone to the cases of tuberculosis is the under-developed and developing regions. The patients that are infected with HIV are more likely to be affected with active tuberculosis. The risk of people suffering from active TB is greater in those that have a low immune system and those who are suffering from other conditions. WHO organization has developed a program to treat tuberculosis known as ‘Directly Observed Treatment, Short Course’, this witnessed rapid development in the global tuberculosis therapeutics market. Lack of anti-tubercular drugs for treating tuberculosis in children will adversely affect the market.
Global Tuberculosis Therapeutics Market: Regional Analysis
The geographical segmentation of the global tuberculosis therapeutics market is diversified into North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific, and the Middle East and Africa. The region that will dominate the tuberculosis therapeutics market is the North America and Latin America regions and this growth will continue in the coming years. People from all the regions are are becoming concerned about their health and are also becoming aware of the treatments for tuberculosis. The Middle East and Africa regions and Asia Pacific regions market are anticipated to grow at a moderate rate.
Global Tuberculosis Therapeutics Market: Competitive Players
The key market players that are involved in the tuberculosis therapeutics market include Aventis Pharmaceuticals Limited, Sanofi -Aventis U.S. LLC, Versapharma Incorporated, Sigma Pharmaceutical Pty Limited, Novartis AG, Hoffmann-La Roche Ltd., and Bayer Health Care.
Global Tuberculosis Therapeutics Market: Regional Segment Analysis
What Reports Provides
Request the coronavirus impact analysis across industries and markets